George A. Scangos
2012 compensation: $11. 3 million
2011 compensation: $11.3 million
The board of Biogen Idec Inc. extended George Scangos’s contract with the same base salary of $1.3 million, but the opportunity to earn more in incentive pay, according to a regulatory filing made on Aug. 26. Scangos’s three-year contract was set to expire in July, but the board of the Weston biotechnology company extended it through July 15, 2014, after which the contract could be extended for additional 12-month periods, the filing said.
Under the new contract, Scangos will be able to earn a bonus of not less than 140 percent of his base salary under the company’s incentive plan.